The role of neoadjuvant chemotherapy in marginally resectable or unresectable stage III non-small cell lung cancer

Neoplasma

Volumn 49, Issue 3, 2002, Pages 189-196

  Spasova I ^a   Petera, J ^a   Hytych, V ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Lung cancer; Neoadjuvant chemotherapy; Surgery; Survival

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; SURVIVAL TIME; THORACOTOMY; TREATMENT PLANNING;

EID: 0036302766     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805
2. The comparison of the results of chest computer tomography scans with the surgical results in lung cancer
3. Pre-operative chemotherapy for stage IIIa non-small cell lung cancer
4. Thoracoscopic staging of non-small cell lung cancer before neoadjuvant therapy
5. An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer
6. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial
7. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)
8. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by post-surgical pathologic staging
9. Neoadjuvant chemotherapy for resectable non-small cell lung cancer
10. Non-parametric estimation from incomplete observations
11. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
12. Summary of the proceedings of the United States - Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998
13. Results of resection in non-oat cell carcinoma of the lung with mediastinal lympho nodes metastases
14. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
15. Reporting the results of cancer treatment
16. A new international staging system for lung cancer
17. Lymph node mapping and curability at various levels of metastases in resected lung cancer
18. Lymph node sampling in lung cancer: How should be done?
19. Premilinary results of neoadjuvant paclitaxel and carboplatin in the treatment of early stage non-small-cell lung cancer
20. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without over metastases
21. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis
22. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitand thoracic radiotherapy and continuous cisplatin infusion in stage III non-small cell lung cancer
23. Comparative merits of thoracoscopy, mediastinoscopy and mediastinotomy for mediastinal biopsy
24. Induction chemotherapy for T4 centrally located non-small cell lung cancer
25. Short-Course induction chemoradiotherapy with paclitaxel for stage III non-small cell lung cancer
26. A randomized trial of mitomycin/ifosfamide/cisplatin chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung
27. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
28. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial
29. Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer
30. Surgical treatment of N2 involed non-small cell lung cancer; the systematic extended lymph node dissection based on the regional lymphatic drainage
31. Induction chemotherapy in marginally resectable or unresectable stage III non-small cell lung cancer (NSCLC)
32. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer
33. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer
34. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses
35. Neoadjuvant chemotherapy of stage III-A and B lung carcinoma using the PACCO regimen
36. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer
37. Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients
38. A phase I/II trial of neoadjuvant chemotherapy with Cisplatin and Vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma